These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 1335102

  • 1. [Prospective study of cytomegalovirus infection in liver transplant recipients].
    Lumbreras C, Otero JR, Aguado JM, Lizasoaín M, Gómez R, García I, Fuertes A, Colina F, Moreno E, Noriega AR.
    Med Clin (Barc); 1992 Oct 10; 99(11):401-5. PubMed ID: 1335102
    [Abstract] [Full Text] [Related]

  • 2. Impact of targeted oral ganciclovir prophylaxis for transplant recipients of livers from cytomegalovirus-seropositive donors.
    Shah T, Lai WK, Mutimer D.
    Transpl Infect Dis; 2005 Jun 10; 7(2):57-62. PubMed ID: 16150091
    [Abstract] [Full Text] [Related]

  • 3. Randomized controlled trial of sequential intravenous and oral ganciclovir versus prolonged intravenous ganciclovir for long-term prophylaxis of cytomegalovirus disease in high-risk cytomegalovirus-seronegative liver transplant recipients with cytomegalovirus-seropositive donors.
    Winston DJ, Busuttil RW.
    Transplantation; 2004 Jan 27; 77(2):305-8. PubMed ID: 14742998
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. HLA-DQ3 is a probable risk factor for CMV infection in high-risk kidney transplant patients.
    Varga M, Rajczy K, Telkes G, Hídvégi M, Péter A, Remport A, Korbonits M, Fazakas J, Toronyi E, Sárváry E, Kóbori L, Járay J.
    Nephrol Dial Transplant; 2008 Aug 27; 23(8):2673-8. PubMed ID: 18332066
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Impact of evolving trends in recipient and donor characteristics on cytomegalovirus infection in liver transplant recipients.
    Singh N, Wannstedt C, Keyes L, Wagener MM, de Vera M, Cacciarelli TV, Gayowski T.
    Transplantation; 2004 Jan 15; 77(1):106-10. PubMed ID: 14724443
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Cytomegalovirus infection and survival in lung transplant recipients.
    Duncan AJ, Dummer JS, Paradis IL, Dauber JH, Yousem SA, Zenati MA, Kormos RL, Griffith BP.
    J Heart Lung Transplant; 1991 Jan 15; 10(5 Pt 1):638-44; discussion 645-6. PubMed ID: 1659899
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Comparison of cytomegalovirus antigenemia and shell vial culture in allogeneic marrow transplantation recipients receiving ganciclovir prophylaxis.
    Nicholson VA, Whimbey E, Champlin R, Abi-Said D, Przepiorka D, Tarrand J, Chan K, Bodey GP, Goodrich JM.
    Bone Marrow Transplant; 1997 Jan 15; 19(1):37-41. PubMed ID: 9012929
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.